Research Shows GPs are Switched on to EPS

New research from doctors.net.uk has revealed that GPs' use of electronic prescriptions is gaining momentum. An online survey of 834 GPs in England found that 15% of respondents had already switched to EPS R2, with 25% of those not currently using electronic prescriptions planning to upgrade in 2014.

The research, conducted on behalf of NHS-contracted mail order pharmacy Pharmacy2U, is the first to present a comprehensive view of the EPS landscape in England.

It showed that many GPs have faith in an electronic future. Forty-three per cent of respondents - including those who have not yet switched - were confident that EPS would enable them to provide a more efficient repeat prescription service.

Confusion over patient choice
But the research also revealed confusion among GPs around the introduction of greater patient choice of pharmacy - a key element of EPS R2, as digital scripts remove the need for patients to take a paper copy to the pharmacy.

Almost half of the GPs surveyed (48%) admitted they did not know enough about the nominations process to explain it to patients. And 46% did not know that under EPS, patients have the freedom to nominate any EPS-enabled pharmacy, anywhere in England.

Despite this confusion, 56% agreed that greater choice of pharmacy was valuable because it allowed patients to find the most convenient option for them.

Teething troubles
The research also explored the practical issues involved in switching to digital prescriptions; 58% of GPs using EPS had experienced teething troubles when switching. Issues included lack of preparation among local pharmacies (55%) lack of DM&D coding (29%) and lack of training for practice staff (37%).

Dr Julian Harrison, a director of Pharmacy2U said: "It's encouraging to see the increased uptake of electronic prescriptions but concerning that a key element of the service - greater patient choice of pharmacy - is not yet fully understood by the profession."

Dr Donya Young, an early adopter of electronic prescriptions, is confident about the efficiency benefits of EPS R2. She said: "It is hard to see any negatives with EPS R2 once you address the initial preparation and staff training. The patients love being able to choose their most convenient pharmacy - wherever and whoever that may be. It has really helped our staff to improve efficiency at the practice, and being able to communicate speedily and accurately with our pharmacy colleagues has to be better and safer for all concerned."

In November 2013, MedeConnect, the research division of doctors.net.uk, surveyed 834 UK-registered GPs working in England to test understanding of different elements of EPS R2

Established in 1999, Pharmacy2U is the UK#s largest dedicated internet and mail order pharmacy. The company provides a free NHS mail order repeat prescription service. The service is enabled for EPS R2, making it an option for any patient whose GP uses electronic prescriptions.

Most Popular Now

AI Distinguishes Glioblastoma from Look-…

A Harvard Medical School–led research team has developed an AI tool that can reliably tell apart two look-alike cancers found in the brain but with different origins, behaviors, and treatments. The...

Overcoming the AI Applicability Crisis a…

Opinion Article by Harry Lykostratis, Chief Executive, Open Medical. The government’s 10 Year Health Plan makes a lot of the potential of AI-software to support clinical decision making, improve productivity, and...

Smart Device Uses AI and Bioelectronics …

As a wound heals, it goes through several stages: clotting to stop bleeding, immune system response, scabbing, and scarring. A wearable device called "a-Heal," designed by engineers at the University...

Dartford and Gravesham Implements Clinis…

Dartford and Gravesham NHS Trust has taken a significant step towards a more digital future by rolling out electronic test ordering using Clinisys ICE. The trust deployed the order communications...

AI Body Composition Measurements can Pre…

Adiposity - or the accumulation of excess fat in the body - is a known driver of cardiometabolic diseases such as heart disease, stroke, type 2 diabetes, and kidney disease...